By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TetraPhase Pharmaceuticals 

480 Arsenal Street
Suite 110
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-715-3600 Fax: 617-926-3557


SEARCH JOBS


Industry
Biotechnology






Company News
TetraPhase Pharmaceuticals To Present At Biocentury’s 2014 Newsmakers In The Biotech Industry Conference 9/18/2014 11:00:04 AM
TetraPhase Pharmaceuticals Announces Positive Oral Dosing Data From Lead-in of IGNITE 2 Phase 3 Trial Of Eravacycline In cUTI Support Advancement To Pivotal Portion 9/3/2014 1:09:15 PM
TetraPhase Pharmaceuticals To Participate In Upcoming Investor Conferences 8/27/2014 9:06:51 AM
TetraPhase Pharmaceuticals To Present Research At ICAAC On Its Novel Chemistry Platform’s Ability To Address Antibiotic Resistance 8/22/2014 8:09:13 AM
TetraPhase Pharmaceuticals To Present Research At ICAAC On Its Novel Chemistry Platform’s Ability To Address Antibiotic Resistance 8/21/2014 8:39:53 AM
TetraPhase Pharmaceuticals Reports Second-Quarter 2014 Financial Results 8/13/2014 7:53:03 AM
TetraPhase Pharmaceuticals To Present At Wedbush Life Sciences Conference 8/6/2014 9:42:18 AM
TetraPhase Pharmaceuticals Completes Enrollment Of IGNITE 1 Eravacycline Phase 3 Clinical Trial in Complicated Intra-abdominal Infections 7/28/2014 8:44:45 AM
TetraPhase Pharmaceuticals To Present At Upcoming Conferences 7/23/2014 10:55:56 AM
TetraPhase Pharmaceuticals Completes Enrollment in Lead-in Portion of IGNITE 2 Eravacycline Phase 3 Clinical Trial in cUTI 6/19/2014 10:20:47 AM
12345678
//-->